The 5th Edition Excellence in Real World Evidence and Data Utilization Conference will provide insights to improve patient outcomes and treatment efficacy through the utilization of real-world data and evidence throughout the drug lifecycle.  Hear from leading industry experts from pharmaceuticals, biotech, and medical device companies with responsibilities with RWE and HEOR across diverse therapeutic expertise that address the interpretation of regulatory guidance, synthesize and model data and evidence, and determine value from the data.

Key Topics

• Rising Above the Noise: Basing Drug Price on Drug Value
• Analyzing RWE to Best Understand Your Patient Population: Diversity & Inclusion Strategies
• Integrating Data Sources for Optimal Success in Randomized Trials and Real World Evidence
• Navigating the Regulatory Guidelines and Guidance for Optimal Submissions, Approvals, and Outcomes
• Dissecting Causal Inference Utilized for Real World Evidence Generation
• Discussing Tokenization of Clinical Trials for (Long Term) Follow Up of Trial Subjects Using RWD.

Read on marcusevans.com

Continue reading at marcusevans.com

Patient Reports And Outcomes Real World Evidence (RWE) Real World Evidence Real World Data

Facebook Share

Twitter Share

Linkedin Share

Email Share